EMA Lapsed: Alisade (fluticasone furoate) — Glaxo Group Ltd.

View source ↗

Summary

The EMA lists Alisade (fluticasone furoate) as lapsed, with withdrawal of its marketing authorization in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis Allergic Perennial
• Rhinitis Allergic Seasonal

Drugs mentioned

• Alisade (fluticasone furoate)

Snippet

Status: Lapsed. Therapeutic area: Rhinitis, Allergic, Perennial;Rhinitis, Allergic, Seasonal. MAH: Glaxo Group Ltd.. Decision date: 17/02/2010